- Deadline
- Due Dec 23, 2027
- Posted
- Nov 22, 2024
- Region
- United States
- Category
- Healthcare
- Notice type
- Grant or funding opportunity
- Documents
- Listing only
Summary
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed) is an open grant or funding opportunity in the healthcare category for United States. It was posted on Nov 22, 2024 and closes on Dec 23, 2027 (396 days from today).
Source and full details on Team
This page shows what the bid is, where and when. The source portal, buyer, official listing link, notice ID and full description are part of the Team plan.
What BidRover found in this bid
- Requirements extractedpending review
- Source documents readlisting only
- Match score for your businessTeam
- Bid / no-bid summaryTeam
Create a free account to browse every open bid in one workspace. Free accounts also get weekly email alerts. Match scores, sources, official links, daily alerts, documents, requirements and team review are on Team.
BidRover lists bids from official public sources. Always confirm requirements, amendments and submission instructions in the official notice before responding.